Table 3.
Parameters |
All IRsb taken together (n = 161) |
PMRc ± GCA (n = 57) |
RAd (n = 49) |
SAe (n = 18) |
GCAf without PMR (n = 10) |
Absence of IR (n = 61) |
Rheumatic diseases without IR (n = 32) |
---|---|---|---|---|---|---|---|
F | 0.88 ± 0.63 | 1.32 ± 0.61 | 0.65 ± 0.41 | 0.69 ± 0.67 | 0.32 ± 0.31 | 0.44 ± 0.31 | 0.45 ± 0.29 |
Nbh | 3.52 ± 4.47 | 6.90 ± 4.88 | 1.53 ± 2.18 | 2.56 ± 4.34 | 0.3 ± 0.67 | 0.62 ± 1.20 | 0.62 ± 1.13 |
m ± s, Mean and standard deviation.
IR, Inflammatory rheumatism.
PMR, Polymyalgia rheumatic.
RA, Rheumatoid arthritis.
SA, Spondyloarthritis.
GCA, Giant cell arteritis.
F17 is the mean FDG uptake score studied in the 17 sites.
Nb is the number of sites with significant uptake (≥ liver uptake).